Don’t miss the latest developments in business and finance.

Strides Arcolab gets USFDA approval for Tacrolimus Capsules

Image
Capital Market
Last Updated : Jul 23 2014 | 11:55 PM IST

To be manufactures at its oral dosage facility in Bangalore

Strides Arcolab announced that the Company has received approval from the United States Food & Drug Administration (USFDA) for for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg.

According to IMS data as on September 2013, the US market for generic for Tacrolimus is approximately USD 676 million.

The product will be manufactured at the Company's oral dosage facility at Bangalore and marketed directly by Strides in the US market.

Powered by Capital Market - Live News

More From This Section

First Published: Jul 23 2014 | 9:34 AM IST

Next Story